Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM – Get Free Report) shares were down 6.6% on Monday . The stock traded as low as C$0.29 and last traded at C$0.29. Approximately 4,800 shares traded hands during trading, an increase of 68% from the average daily volume of 2,858 shares. The stock had previously closed at C$0.31.
Zomedica Pharmaceuticals Corp. (ZOM.V) Stock Down 6.6 %
The firm has a market cap of C$36.73 million and a PE ratio of -2.61. The company has a debt-to-equity ratio of 4.91, a quick ratio of 15.25 and a current ratio of 15.31. The company’s 50-day simple moving average is C$0.29 and its two-hundred day simple moving average is C$0.28.
About Zomedica Pharmaceuticals Corp. (ZOM.V)
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies.
Featured Stories
- Five stocks we like better than Zomedica Pharmaceuticals Corp. (ZOM.V)
- What is the S&P 500 and How It is Distinct from Other Indexes
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to buy stock: A step-by-step guide for beginners
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Zomedica Pharmaceuticals Corp. (ZOM.V) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica Pharmaceuticals Corp. (ZOM.V) and related companies with MarketBeat.com's FREE daily email newsletter.